KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis
- PMID: 25985364
- PMCID: PMC4552085
- DOI: 10.1038/nm.3866
KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis
Erratum in
-
Corrigendum: KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis.Nat Med. 2016 Feb;22(2):217. doi: 10.1038/nm0216-217a. Nat Med. 2016. PMID: 26845408 Free PMC article. No abstract available.
Abstract
Previous studies investigating the role of smooth muscle cells (SMCs) and macrophages in the pathogenesis of atherosclerosis have provided controversial results owing to the use of unreliable methods for clearly identifying each of these cell types. Here, using Myh11-CreER(T2) ROSA floxed STOP eYFP Apoe(-/-) mice to perform SMC lineage tracing, we find that traditional methods for detecting SMCs based on immunostaining for SMC markers fail to detect >80% of SMC-derived cells within advanced atherosclerotic lesions. These unidentified SMC-derived cells exhibit phenotypes of other cell lineages, including macrophages and mesenchymal stem cells (MSCs). SMC-specific conditional knockout of Krüppel-like factor 4 (Klf4) resulted in reduced numbers of SMC-derived MSC- and macrophage-like cells, a marked reduction in lesion size, and increases in multiple indices of plaque stability, including an increase in fibrous cap thickness as compared to wild-type controls. On the basis of in vivo KLF4 chromatin immunoprecipitation-sequencing (ChIP-seq) analyses and studies of cholesterol-treated cultured SMCs, we identified >800 KLF4 target genes, including many that regulate pro-inflammatory responses of SMCs. Our findings indicate that the contribution of SMCs to atherosclerotic plaques has been greatly underestimated, and that KLF4-dependent transitions in SMC phenotype are critical in lesion pathogenesis.
Figures






Similar articles
-
Stem Cell Pluripotency Genes Klf4 and Oct4 Regulate Complex SMC Phenotypic Changes Critical in Late-Stage Atherosclerotic Lesion Pathogenesis.Circulation. 2020 Nov 24;142(21):2045-2059. doi: 10.1161/CIRCULATIONAHA.120.046672. Epub 2020 Jul 17. Circulation. 2020. PMID: 32674599 Free PMC article.
-
Klf4 has an unexpected protective role in perivascular cells within the microvasculature.Am J Physiol Heart Circ Physiol. 2018 Aug 1;315(2):H402-H414. doi: 10.1152/ajpheart.00084.2018. Epub 2018 Apr 6. Am J Physiol Heart Circ Physiol. 2018. PMID: 29631369 Free PMC article.
-
Cholesterol-Induced Phenotypic Modulation of Smooth Muscle Cells to Macrophage/Fibroblast-like Cells Is Driven by an Unfolded Protein Response.Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):302-316. doi: 10.1161/ATVBAHA.120.315164. Epub 2020 Oct 8. Arterioscler Thromb Vasc Biol. 2021. PMID: 33028096 Free PMC article.
-
Smooth muscle cell phenotypic switch: implications for foam cell formation.Curr Opin Lipidol. 2014 Oct;25(5):374-9. doi: 10.1097/MOL.0000000000000113. Curr Opin Lipidol. 2014. PMID: 25110900 Review.
-
Smooth muscle cell fate and plasticity in atherosclerosis.Cardiovasc Res. 2018 Mar 15;114(4):540-550. doi: 10.1093/cvr/cvy022. Cardiovasc Res. 2018. PMID: 29385543 Free PMC article. Review.
Cited by
-
TXNIP Suppresses the Osteochondrogenic Switch of Vascular Smooth Muscle Cells in Atherosclerosis.Circ Res. 2023 Jan 6;132(1):52-71. doi: 10.1161/CIRCRESAHA.122.321538. Epub 2022 Nov 30. Circ Res. 2023. PMID: 36448450 Free PMC article.
-
Global trends and Frontier topics about vascular smooth muscle cells phenotype switch: A bibliometric analysis from 1999 to 2021.Front Pharmacol. 2022 Nov 14;13:1004525. doi: 10.3389/fphar.2022.1004525. eCollection 2022. Front Pharmacol. 2022. PMID: 36452231 Free PMC article.
-
Heterogeneous subpopulations of adventitial progenitor cells regulate vascular homeostasis and pathological vascular remodelling.Cardiovasc Res. 2022 May 6;118(6):1452-1465. doi: 10.1093/cvr/cvab174. Cardiovasc Res. 2022. PMID: 33989378 Free PMC article. Review.
-
The Role of Transcription Factor 21 in Epicardial Cell Differentiation and the Development of Coronary Heart Disease.Front Cell Dev Biol. 2020 Jun 5;8:457. doi: 10.3389/fcell.2020.00457. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32582717 Free PMC article. Review.
-
Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas.Circ Res. 2020 Jul 17;127(3):402-426. doi: 10.1161/CIRCRESAHA.120.316903. Epub 2020 Jul 16. Circ Res. 2020. PMID: 32673538 Free PMC article. Review.
References
-
- Saffitz JE, Schwartz CJ. Coronary atherosclerosis and thrombosis underlying acute myocardial infarction. Cardiol. Clin. 1987;5:21–30. - PubMed
-
- Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat. Med. 2002;8:1257–1262. - PubMed
-
- Falk E, Nakano M, Benton JF, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists' view. Eur. Heart J. 2012 - PubMed
-
- Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657–671. - PubMed
-
- Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 2000;20:1262–1275. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
- HL087867/HL/NHLBI NIH HHS/United States
- R37 HL057353/HL/NHLBI NIH HHS/United States
- P30 CA044579/CA/NCI NIH HHS/United States
- HL112904/HL/NHLBI NIH HHS/United States
- R00 HL112904/HL/NHLBI NIH HHS/United States
- K99 HL112904/HL/NHLBI NIH HHS/United States
- R01 HL087867/HL/NHLBI NIH HHS/United States
- R01 HL088554/HL/NHLBI NIH HHS/United States
- T32 HL007284/HL/NHLBI NIH HHS/United States
- R01 HL057353/HL/NHLBI NIH HHS/United States
- R01 HL121008/HL/NHLBI NIH HHS/United States
- R01 HL098538/HL/NHLBI NIH HHS/United States
- T32 CA009109/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous